1
|
Wang M, Xu H, Xiong X, Chang L, Zhang K, Zhou Y, Zhang F, Awadasseid A, Zhang W. Antiproliferative activity of selenium-enriched coumarin derivatives on the SK-N-SH neuroblastoma cell line: Mechanistic insights. Eur J Med Chem 2025; 286:117322. [PMID: 39884097 DOI: 10.1016/j.ejmech.2025.117322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2024] [Revised: 01/21/2025] [Accepted: 01/22/2025] [Indexed: 02/01/2025]
Abstract
Thirty selenium-containing coumarin derivatives were synthesized and evaluated for inhibitory activity against 17 malignant tumor cell lines. Among these, compound 11i demonstrated the most potent inhibition of neuroblastoma SK-N-SH cells, with an IC50 of 2.5 ± 0.1 μM. Compound 11i notably inhibited SK-N-SH cell proliferation, migration, and invasion. Western blot and immunofluorescence analyses indicated that 11i increased the Bax/Bcl-2 protein expression ratio, promoted Cytochrome C release from mitochondria, and activated caspases 9 and 3, triggering the mitochondria-mediated apoptotic pathway and inducing endogenous tumor cell apoptosis. The compounds localized in the cytoplasm and co-localized with mitochondria, suggesting mitochondrial interaction and dysfunction. Computational docking studies revealed a strong binding affinity of 11i with Bcl-2 and mitochondrial G-quadruplexes. In a subcutaneous neuroblastoma-bearing mouse model, 11i showed notable anti-tumor efficacy with tumor inhibition rates of 79 % (10 mg/kg) and 93 % (20 mg/kg), exceeding that of cyclophosphamide. This study represents a novel finding on the anti-tumor activity of selenium-containing coumarin derivatives and provides a theoretical basis for developing coumarin-based therapeutics for neuroblastoma.
Collapse
Affiliation(s)
- Ming Wang
- Lab of Chemical Biology and Molecular Drug Design, College of Pharmaceutical Science, Zhejiang University of Technology, Deqing, 313299, China; Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Deqing, 313299, China
| | - Haoran Xu
- Lab of Chemical Biology and Molecular Drug Design, College of Pharmaceutical Science, Zhejiang University of Technology, Deqing, 313299, China; Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Deqing, 313299, China
| | - Xuqiong Xiong
- Lab of Chemical Biology and Molecular Drug Design, College of Pharmaceutical Science, Zhejiang University of Technology, Deqing, 313299, China; Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Deqing, 313299, China
| | - Linru Chang
- Lab of Chemical Biology and Molecular Drug Design, College of Pharmaceutical Science, Zhejiang University of Technology, Deqing, 313299, China; Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Deqing, 313299, China
| | - Koutian Zhang
- Zhejiang Qingzhenghong Technology Co., Ltd, Hangzhou, 311121, China
| | - Yongnan Zhou
- Lab of Chemical Biology and Molecular Drug Design, College of Pharmaceutical Science, Zhejiang University of Technology, Deqing, 313299, China; Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Deqing, 313299, China
| | - Feng Zhang
- Lab of Chemical Biology and Molecular Drug Design, College of Pharmaceutical Science, Zhejiang University of Technology, Deqing, 313299, China; Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Deqing, 313299, China
| | - Annoor Awadasseid
- Lab of Chemical Biology and Molecular Drug Design, College of Pharmaceutical Science, Zhejiang University of Technology, Deqing, 313299, China; Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Deqing, 313299, China; Zhejiang Qingzhenghong Technology Co., Ltd, Hangzhou, 311121, China.
| | - Wen Zhang
- Lab of Chemical Biology and Molecular Drug Design, College of Pharmaceutical Science, Zhejiang University of Technology, Deqing, 313299, China; Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Deqing, 313299, China; Zhejiang Jieyuan Med-Tech Co., Ltd., Hangzhou, 311113, China.
| |
Collapse
|
2
|
Yi ZQ, Zhang W, Yi B, Liu C, Xie Y, Li M, Xiong Y, Wu W, Tan JP. Stereoselective Synthesis of Biology-Oriented Pentacyclic Pyrrolo[2,1- a]isoquinoline Scaffolds by Photoredox-Induced Radical Annulations. Org Lett 2025; 27:2197-2202. [PMID: 40007134 DOI: 10.1021/acs.orglett.5c00277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/27/2025]
Abstract
We report a visible-light photoredox-induced stereoselective radical 1,3-dipolar cycloaddition between tetrahydroisoquinolines and coumarin derivatives, providing a platform for the efficient synthesis of pseudo-natural-inspired fused pentacyclic scaffolds. Using this protocol, a diverse range of valuable fused pentacyclic pyrrolo[2,1-a]isoquinolines were efficiently obtained in moderate to good yields and excellent diastereoselectivities. Mechanistic investigations including radical control experiments and light on/off studies indicated that the reaction underwent a visible-light induced radical process. The insights gained from our studies are expected to advance general efforts toward the green synthesis of biology-oriented pseudo-natural products and heterocyclic skeletons.
Collapse
Affiliation(s)
- Zi-Qi Yi
- School of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201210, P. R. China
| | - Wenhui Zhang
- Key Laboratory of Environmental Catalysis and Waste Recycling of Hunan Province, College of Materials and Chemical Engineering, Institute of Advanced Functional Materials, Hunan Institute of Engineering, Xiangtan 411104, P. R. China
| | - Bing Yi
- Key Laboratory of Environmental Catalysis and Waste Recycling of Hunan Province, College of Materials and Chemical Engineering, Institute of Advanced Functional Materials, Hunan Institute of Engineering, Xiangtan 411104, P. R. China
| | - Chang Liu
- Key Laboratory of Environmental Catalysis and Waste Recycling of Hunan Province, College of Materials and Chemical Engineering, Institute of Advanced Functional Materials, Hunan Institute of Engineering, Xiangtan 411104, P. R. China
| | - Yanjun Xie
- Key Laboratory of Environmental Catalysis and Waste Recycling of Hunan Province, College of Materials and Chemical Engineering, Institute of Advanced Functional Materials, Hunan Institute of Engineering, Xiangtan 411104, P. R. China
| | - Maoqing Li
- Key Laboratory of Environmental Catalysis and Waste Recycling of Hunan Province, College of Materials and Chemical Engineering, Institute of Advanced Functional Materials, Hunan Institute of Engineering, Xiangtan 411104, P. R. China
| | - Yi Xiong
- Key Laboratory of Environmental Catalysis and Waste Recycling of Hunan Province, College of Materials and Chemical Engineering, Institute of Advanced Functional Materials, Hunan Institute of Engineering, Xiangtan 411104, P. R. China
| | - Weidong Wu
- Key Laboratory of Environmental Catalysis and Waste Recycling of Hunan Province, College of Materials and Chemical Engineering, Institute of Advanced Functional Materials, Hunan Institute of Engineering, Xiangtan 411104, P. R. China
| | - Jian-Ping Tan
- Key Laboratory of Environmental Catalysis and Waste Recycling of Hunan Province, College of Materials and Chemical Engineering, Institute of Advanced Functional Materials, Hunan Institute of Engineering, Xiangtan 411104, P. R. China
- Key Laboratory of Green Chemistry & Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, P. R. China
| |
Collapse
|
3
|
Jiménez-Rodríguez A, Alvarado-Sánchez C, Velasco M, López-Oliva E, Romero-Ceronio N, Ortiz-Andrade R, Hernández-Abreu O. Dual Relaxant Effect of Coumarin-3-carboxamides Through the Nitric Oxide/Cyclic Guanosine Monophosphate Pathway and Ca 2+ Channels Blockade. Chem Biodivers 2025:e202403028. [PMID: 39890588 DOI: 10.1002/cbdv.202403028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2024] [Revised: 01/21/2025] [Accepted: 01/31/2025] [Indexed: 02/03/2025]
Abstract
We aimed to determine the relaxant pathway of seventeen synthetic compounds derived from coumarin-3-carboxamide. An isolated rat aorta assay was used. To determine the vasorelaxant mode of action, receptor blockers and specific enzyme inhibitors involved in endothelial and smooth muscle signaling pathways were used. The compounds 2, 4, and 5 showed higher activity than the other compounds. N-nitro-L-arginine methyl ester (10 µM) and methylene blue (10 µM) significantly inhibited the relaxant effect of the compounds 2, 4, and 5 (p ≤ 0.05), but not tetraethylammonium (5 mM), indomethacin (10 µM), or atropine (1 µM). The compounds 2, 4, and 5 abated the contraction induced by CaCl2. The compounds 2, 4, and 5 exert a relaxing effect through the nitric oxide/cyclic guanosine monophosphate pathway activation and by blocking Ca2+ channels of the cell membrane. These findings propose coumarin-3-carboxamides as new drug entities with the potential to develop non-clinical and clinical.
Collapse
Affiliation(s)
- Arabelly Jiménez-Rodríguez
- Laboratorio de Química Farmacéutica y Productos Naturales, Centro de Investigación de Ciencia y Tecnología Aplicada de Tabasco (CICTAT), Universidad Juárez Autónoma de Tabasco, Cunduacán, Mexico
| | - Cuauhtémoc Alvarado-Sánchez
- Laboratorio de Química Farmacéutica y Productos Naturales, Centro de Investigación de Ciencia y Tecnología Aplicada de Tabasco (CICTAT), Universidad Juárez Autónoma de Tabasco, Cunduacán, Mexico
| | - Manuel Velasco
- Complejo Regional Mixteca, Campus Chiautla de Tapia, Benemérita Universidad Autónoma de Puebla, Chiautla de Tapia, Mexico
| | - Estephania López-Oliva
- Laboratorio de Química Farmacéutica y Productos Naturales, Centro de Investigación de Ciencia y Tecnología Aplicada de Tabasco (CICTAT), Universidad Juárez Autónoma de Tabasco, Cunduacán, Mexico
| | - Nancy Romero-Ceronio
- Laboratorio de Química Farmacéutica y Productos Naturales, Centro de Investigación de Ciencia y Tecnología Aplicada de Tabasco (CICTAT), Universidad Juárez Autónoma de Tabasco, Cunduacán, Mexico
| | | | - Oswaldo Hernández-Abreu
- Laboratorio de Química Farmacéutica y Productos Naturales, Centro de Investigación de Ciencia y Tecnología Aplicada de Tabasco (CICTAT), Universidad Juárez Autónoma de Tabasco, Cunduacán, Mexico
| |
Collapse
|
4
|
Wang H, Hu S, Pei Y, Sun H. Nordalbergin Synergizes with Novel β-Lactam Antibiotics against MRSA Infection. Int J Mol Sci 2024; 25:7704. [PMID: 39062947 PMCID: PMC11277203 DOI: 10.3390/ijms25147704] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2024] [Revised: 07/11/2024] [Accepted: 07/11/2024] [Indexed: 07/28/2024] Open
Abstract
The synergetic strategy has created tremendous advantages in drug-resistance bacterial infection treatment, whereas challenges related to novel compound discovery and identifying drug-binding targets still remain. The mechanisms of antimicrobial resistance involving β-lactamase catalysis and the degradation of β-lactam antibiotics are being revealed, with relevant therapies promising to improve the efficacy of existing major classes of antibiotics in the foreseeable future. In this study, it is demonstrated that nordalbergin, a coumarin isolated from the wood bark of Dalbergia sissoo, efficiently potentiated the activities of β-lactam antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by suppressing β-lactamase performance and improving the bacterial biofilm susceptibility to antibiotics. Nordalbergin was found to destabilize the cell membrane and promote its permeabilization. Moreover, nordalbergin efficiently improved the therapeutic efficacy of amoxicillin against MRSA pneumonia in mice, as supported by the lower bacterial load, attenuated pathological damage, and decreased inflammation level. These results demonstrate that nordalbergin might be a promising synergist of amoxicillin against MRSA infections. This study provided a new approach for developing potentiators for β-lactam antibiotics against MRSA infections.
Collapse
Affiliation(s)
- Haiting Wang
- College of Animal Sciences, Zhejiang University, Hangzhou 310058, China;
| | - Sangyu Hu
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun 130062, China; (S.H.); (Y.P.)
- Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun 130062, China
| | - Yuzhu Pei
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun 130062, China; (S.H.); (Y.P.)
- Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun 130062, China
| | - Hongxiang Sun
- College of Animal Sciences, Zhejiang University, Hangzhou 310058, China;
| |
Collapse
|
5
|
Eddahmi M, La Spada G, Domingo LR, Vergoten G, Bailly C, Catto M, Bouissane L. Synthesis, Molecular Electron Density Theory Study, Molecular Docking, and Pharmacological Evaluation of New Coumarin-Sulfonamide-Nitroindazolyl-Triazole Hybrids as Monoamine Oxidase Inhibitors. Int J Mol Sci 2024; 25:6803. [PMID: 38928509 PMCID: PMC11203676 DOI: 10.3390/ijms25126803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2024] [Revised: 06/16/2024] [Accepted: 06/17/2024] [Indexed: 06/28/2024] Open
Abstract
Inhibitors of monoamine oxidases (MAOs) are of interest for the treatment of neurodegenerative disorders and other human pathologies. In this frame, the present work describes different synthetic strategies to obtain MAO inhibitors via the coupling of the aminocoumarin core with arylsulfonyl chlorides followed by copper azide-alkyne cycloaddition, leading to coumarin-sulfonamide-nitroindazolyl-triazole hybrids. The nitration position on the coumarin moiety was confirmed through nuclear magnetic resonance spectroscopy and molecular electron density theory in order to elucidate the molecular mechanism and selectivity of the electrophilic aromatic substitution reaction. The coumarin derivatives were evaluated for their inhibitory potency against monoamine oxidases and cholinesterases. Molecular docking calculations provided a rational binding mode of the best compounds in the series with MAO A and B. The work identified hybrids 14a-c as novel MAO inhibitors, with a selective action against isoform B, of potential interest to combat neurological diseases.
Collapse
Affiliation(s)
- Mohammed Eddahmi
- Molecular Chemistry, Materials and Catalysis Laboratory, Faculty of Sciences and Technologies, Sultan Moulay Slimane University, BP 523, Beni-Mellal 23000, Morocco;
| | - Gabriella La Spada
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy; (G.L.S.); (M.C.)
| | - Luis R. Domingo
- Department of Organic Chemistry, University of Valencia, Dr. Moliner 50, 46100 Burjassot, Valencia, Spain;
| | - Gérard Vergoten
- Institute of Pharmaceutical Chemistry Albert Lespagnol (ICPAL), Faculty of Pharmacy, University of Lille, Rue du Professeur Laguesse, BP-83, F-59006 Lille, France
| | - Christian Bailly
- Institute of Pharmaceutical Chemistry Albert Lespagnol (ICPAL), Faculty of Pharmacy, University of Lille, Rue du Professeur Laguesse, BP-83, F-59006 Lille, France
| | - Marco Catto
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy; (G.L.S.); (M.C.)
| | - Latifa Bouissane
- Molecular Chemistry, Materials and Catalysis Laboratory, Faculty of Sciences and Technologies, Sultan Moulay Slimane University, BP 523, Beni-Mellal 23000, Morocco;
| |
Collapse
|
6
|
Wang T, Gao Y, Wu F, Luo L, Ma J, Hu Y. Coumarin-furo[2,3- d]pyrimidone hybrid molecules targeting human liver cancer cells: synthesis, anticancer effect, EGFR inhibition and molecular docking studies. RSC Med Chem 2024; 15:1565-1577. [PMID: 38784474 PMCID: PMC11110736 DOI: 10.1039/d3md00668a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2023] [Accepted: 03/16/2024] [Indexed: 05/25/2024] Open
Abstract
The design, synthesis and investigation of antitumor activities of some coumarin-furo[2,3-d]pyrimidone hybrid molecules are reported. In vitro, HepG2 cells were used to investigate the cytotoxicity of 6a-n and 10a-n. The results demonstrated that coupling a furopyrimidone scaffold with coumarin through a hydrazide linker can effectively improve their synergistic anticancer activity. The coumarin-furo[2,3-d]pyrimidone combination 10a exhibited significant inhibitory activity against HepG2 cells with IC50 = 7.72 ± 1.56 μM, which is better than those of gefitinib and sorafenib. It is worth mentioning that the coumarin-furo[2,3-d]pyrimidone combination 10a showed excellent inhibition of the EGFR enzymatic activity with IC50 = 1.53 μM and 90% inhibition at 10 μM concentration. In silico investigation predicts the possibility of direct binding between the new coumarin-furo[2,3-d]pyrimidone hybrid molecules and the EGFR. The results suggest that coumarin-furo[2,3-d]pyrimidone hybrid molecules are potential antitumor agents targeting human liver cancer cells.
Collapse
Affiliation(s)
- Tianshuai Wang
- School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China
- Hubei Key Lab of Wudang Local Chinese Medicine Research, School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China
| | - Yumeng Gao
- School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China
| | - Fengxu Wu
- School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China
- Hubei Key Lab of Wudang Local Chinese Medicine Research, School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China
| | - Lun Luo
- School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China
- Hubei Key Lab of Wudang Local Chinese Medicine Research, School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China
| | - Junkai Ma
- School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China
- Hubei Key Lab of Wudang Local Chinese Medicine Research, School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China
| | - Yanggen Hu
- School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China
- Hubei Key Lab of Wudang Local Chinese Medicine Research, School of Pharmacy, Hubei University of Medicine Shiyan 442000 Hubei China
| |
Collapse
|
7
|
Citarella A, Vittorio S, Dank C, Ielo L. Syntheses, reactivity, and biological applications of coumarins. Front Chem 2024; 12:1362992. [PMID: 38440776 PMCID: PMC10909861 DOI: 10.3389/fchem.2024.1362992] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2023] [Accepted: 02/05/2024] [Indexed: 03/06/2024] Open
Abstract
This comprehensive review, covering 2021-2023, explores the multifaceted chemical and pharmacological potential of coumarins, emphasizing their significance as versatile natural derivatives in medicinal chemistry. The synthesis and functionalization of coumarins have advanced with innovative strategies. This enabled the incorporation of diverse functional fragments or the construction of supplementary cyclic architectures, thereby the biological and physico-chemical properties of the compounds obtained were enhanced. The unique chemical structure of coumarine facilitates binding to various targets through hydrophobic interactions pi-stacking, hydrogen bonding, and dipole-dipole interactions. Therefore, this important scaffold exhibits promising applications in uncountable fields of medicinal chemistry (e.g., neurodegenerative diseases, cancer, inflammation).
Collapse
Affiliation(s)
- Andrea Citarella
- Dipartimento di Chimica, Università degli Studi di Milano, Milano, Italy
| | - Serena Vittorio
- Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Milano, Italy
| | - Christian Dank
- Institute of Organic Chemistry, University of Vienna, Vienna, Austria
| | - Laura Ielo
- Department of Chemistry, University of Turin, Turin, Italy
| |
Collapse
|
8
|
Singh GT, Murugan P S, Kumar SP, Krishnan M, Khuntia S. Comparison of Efficacy of Coumarin and Chymotrypsin/Trypsin in Patients Undergoing Surgical Removal of Lower Third Molars: A Prospective Study. Cureus 2023; 15:e50750. [PMID: 38239527 PMCID: PMC10794793 DOI: 10.7759/cureus.50750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2023] [Accepted: 12/18/2023] [Indexed: 01/22/2024] Open
Abstract
Background Third-molar surgeries are very commonly done by oral and maxillofacial surgeons. Pain and swelling that is associated with this procedure is a frequent reason for the patient's discomfort and apprehension. There is a need to look for a drug that can substantially reduce postoperative swelling amongst the patients. Pain, swelling, and trismus are common complications that are encountered after third molar surgery. These complications have a major impact on the quality of life of patients undergoing minor surgical procedures. Aim The aim of this study was to compare the effectiveness of coumarin and trypsin/chymotrypsin in the reduction of postoperative sequelae for mandibular third molar surgeries. Materials and methods The research was carried out at Saveetha Dental College and Hospital in the Department of Oral and Maxillofacial Surgery. The study consisted of 50 individuals, 25 individuals received tablets of coumarin, and 25 individuals received tablets containing a combination of trypsin/chymotrypsin postoperatively. Patients were evaluated postoperatively for pain and swelling. Postoperative pain was measured on days one, three, and seven after surgery using a visual analog scale. The postoperative swelling was measured on postoperative days three and day seven via a four-point technique. Data were analyzed using IBM SPSS Statistics for Windows, Version 23 (Released 2015; IBM Corp., Armonk, New York, United States). P-values less than 0.05 were considered statistically significant. The independent samples t-test was used to compare the outcomes between the two groups. Results It was found that study participants in the trypsin/chymotrypsin group reported statistically significantly less pain postoperatively than participants receiving coumarin (p=0.001). There was more reduction in swelling postoperatively in patients who were given trypsin/chymotrypsin as compared to the participants who were given coumarin, and the results were statistically significant. Conclusion Based on the data obtained, it can be inferred that the trypsin/chymotrypsin combination was more effective in reducing postoperative sequelae like pain and swelling than coumarin in the mandibular third molar surgeries.
Collapse
Affiliation(s)
- Gurmehr T Singh
- Oral and Maxillofacial Surgery, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND
| | - Senthil Murugan P
- Oral and Maxillofacial Surgery, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND
| | - Santhosh P Kumar
- Oral and Maxillofacial Surgery, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND
| | - Murugesan Krishnan
- Oral and Maxillofacial Surgery, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND
| | - Sibashish Khuntia
- Oral and Maxillofacial Surgery, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND
| |
Collapse
|
9
|
Castanha APM, Almeida-Terassi LM, Guardado-Yordi E, Matos MJ, Maistro EL. Cytogenotoxicity assessment of 3-(3,4-dihydroxyphenyl)-7,8-dihydroxycoumarin on HepG2/C3A cells and leukocytes. J Appl Toxicol 2023; 43:323-334. [PMID: 36000810 DOI: 10.1002/jat.4384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Revised: 08/17/2022] [Accepted: 08/21/2022] [Indexed: 01/17/2023]
Abstract
3-(3,4-Dihydroxyphenyl)-7,8-dihydroxycoumarin is a newly synthesized coumarin derivative with a potent antioxidant effect. The aim of the present study is to investigate the safety of this compound, determining the in vitro cytotoxic and genotoxic in human peripheral blood mononuclear cells (PBMC) and in HepG2/C3A cells. Cell viability has been investigated by the trypan blue staining test and MTT assay and the genotoxicity by the comet assay and micronucleus test, using concentrations between 0.01 and 10 μg/ml. The compound proved to be noncytotoxic in both cell lines, at all tested concentrations, protecting the cells from the DNA damage. In addition, this molecule does not show clastogenic/aneugenic effects when performing the micronucleus test with cytokinesis blockade. Based on the obtained data, and the conditions of the experiments, we can conclude that the 3-(3,4-dihydroxyphenyl)-7,8-dihydroxycoumarin is a safe molecule up to a concentration of 10 μg/ml, which encourages further studies aiming to explore its potential as a drug candidate.
Collapse
Affiliation(s)
| | | | | | - Maria João Matos
- Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, Spain.,CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal
| | - Edson Luis Maistro
- Marilia Medical School, FAMEMA, Marilia, Brazil.,Faculty of Philosophy and Sciences, Speech and Hearing Therapy Department, São Paulo State University-UNESP, Marília, Brazil
| |
Collapse
|
10
|
Shankar M, Kumara Swamy KC. Ru( ii)-catalysed oxidative (4 + 2) annulation of chromene and coumarin carboxylic acids with alkynes/propargylic alcohols: isolation of Ru(0) complexes. Org Biomol Chem 2023; 21:195-208. [DOI: 10.1039/d2ob01890j] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Ru(ii)-catalysed oxidative (4 + 2) annulation of chromene and coumarin carboxylic acids with alkynes affords pyrano-chromones via vinylic C–H bond activation; use of methyl-tethered propargylic alcohols instead of alkynes gives Ru(0) complexes.
Collapse
Affiliation(s)
- Mallepalli Shankar
- School of Chemistry, University of Hyderabad, Hyderabad 500 046, Telangana, India
| | - K. C. Kumara Swamy
- School of Chemistry, University of Hyderabad, Hyderabad 500 046, Telangana, India
| |
Collapse
|
11
|
Luo Y, Luo X, Zhang T, Li S, Liu S, Ma Y, Wang Z, Jin X, Liu J, Wang X. Anti-Tumor Secondary Metabolites Originating from Fungi in the South China Sea's Mangrove Ecosystem. BIOENGINEERING (BASEL, SWITZERLAND) 2022; 9:bioengineering9120776. [PMID: 36550982 PMCID: PMC9774444 DOI: 10.3390/bioengineering9120776] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Revised: 11/14/2022] [Accepted: 11/28/2022] [Indexed: 12/13/2022]
Abstract
A mangrove is a unique ecosystem with abundant resources, in which fungi are an indispensable microbial part. Numerous mangrove fungi-derived secondary metabolites are considerable sources of novel bioactive substances, such as polyketides, terpenoids, alkaloids, peptides, etc., which arouse people's interest in the search for potential natural anti-tumor drugs. This review includes a total of 44 research publications that described 110 secondary metabolites that were all shown to be anti-tumor from 39 mangrove fungal strains belonging to 18 genera that were acquired from the South China Sea between 2016 and 2022. To identify more potential medications for clinical tumor therapy, their sources, unique structures, and cytotoxicity qualities were compiled. This review could serve as a crucial resource for the research status of mangrove fungal-derived natural products deserving of further development.
Collapse
Affiliation(s)
- Yuyou Luo
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
| | - Xiongming Luo
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
- Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou 510006, China
| | - Tong Zhang
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
| | - Siyuan Li
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
| | - Shuping Liu
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
| | - Yuxin Ma
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
| | - Zongming Wang
- Pituitary Tumor Center, Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
| | - Xiaobao Jin
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
- Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou 510006, China
| | - Jing Liu
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
- Correspondence: (J.L.); (X.W.); Tel.: +86-134-2412-4716 (J.L.); +86-20-39352189 (X.W.)
| | - Xin Wang
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
- Correspondence: (J.L.); (X.W.); Tel.: +86-134-2412-4716 (J.L.); +86-20-39352189 (X.W.)
| |
Collapse
|
12
|
Zhang C, Tian Q, Li Y. Design, synthesis, and insecticidal activity evaluation of piperine derivatives. Front Chem 2022; 10:973630. [PMID: 35958231 PMCID: PMC9360595 DOI: 10.3389/fchem.2022.973630] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2022] [Accepted: 07/01/2022] [Indexed: 11/17/2022] Open
Abstract
Structural optimization of natural products has become one of the most effective ways to develop novel pesticides. In this study, 30 novel pesticide derivatives containing a linear bisamide were synthesized. Then, their insecticidal activities against P. xylostella were evaluated. Results indicate that different bisamide substitutes show different larvicidal structure–activity relationships. At the same time, 2-trifluoroethyl is the most efficient substituent. The bioactivity results showed that most of the desired compounds exhibited better insecticidal activity against P. xylostella than piperine. Among them, compound D28 resulted in 90% mortality at 1 mg/ml concentration. This study provides a novel protocol for the discovery of new insecticides. The molecular docking results indicated that compound D28 could act on γ-aminobutyric acid receptors.
Collapse
Affiliation(s)
- Chiying Zhang
- Key Laboratory of Agri-Food Safety of Anhui Province, School of Resources and Environment, Anhui Agricultural University, Hefei, China
| | - Qingqiang Tian
- Key Laboratory of Agri-Food Safety of Anhui Province, School of Resources and Environment, Anhui Agricultural University, Hefei, China
| | - Yahui Li
- Key Laboratory of Agri-Food Safety of Anhui Province, School of Resources and Environment, Anhui Agricultural University, Hefei, China
- State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide and Agricultural Bio-engineering, Ministry of Education, Guizhou University, Guiyang, China
- *Correspondence: Yahui Li,
| |
Collapse
|
13
|
Duan Y, Zhu HL. Privileged Scaffold for Drug Design and Activity Improvement - Part IV. Curr Top Med Chem 2022; 22:268. [PMID: 35291933 DOI: 10.2174/156802662204220210163610] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Yongtao Duan
- Henan Provincial Key Laboratory of Children\'s Genetics and Metabolic Diseases
Children\'s Hospital Affiliated with Zhengzhou University
Henan Children’s Hospital
Zhengzhou Children’s Hospital
Zhengzhou University
Zhengzhou 450018
China
| | - Hai-liang Zhu
- Henan Provincial Key Laboratory of Children\'s Genetics and Metabolic Diseases
Children\'s Hospital Affiliated with Zhengzhou University
Henan Children’s Hospital
Zhengzhou Children’s Hospital
Zhengzhou University
Zhengzhou 450018
China
| |
Collapse
|